Around the Region

Biogen Idec extends CEO’s contract


The board of Biogen Idec Inc. has extended the contract of its top executive with the same base salary, but with an opportunity to earn more in incentive pay.

Chief executive George A. Scangos’s three-year contract was set to expire last month, but the board of the Weston biotechnology company extended it through July 15, 2014, after which the contract could be extended for additional 12-month periods, according to a Biogen Idec regulatory filing late Monday afternoon.

Under the new contract, Scangos will receive an annual base salary at his current rate of $1.3 million. He will also be able to earn a bonus of not less than 140 percent of his base salary under the company’s incentive plan— up from 130 percent in the previous contract — and will continue to be eligible to receive stock grants under an equity plan for senior executives.

Robert Weisman can be reached at Follow him on Twitter @GlobeRobW.
Loading comments...
Real journalists. Real journalism. Subscribe to The Boston Globe today.
You're reading  1 of 5 free articles.
Get UNLIMITED access for only 99¢ per week Subscribe Now >
You're reading1 of 5 free articles.Keep scrolling to see more articles recomended for you Subscribe now
We hope you've enjoyed your 5 free articles.
Continue reading by subscribing to for just 99¢.
 Already a member? Log in Home
Subscriber Log In

We hope you've enjoyed your 5 free articles'

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than 25¢ a week
Marketing image of
Marketing image of